FTC Judge Rejects Challenge To Illumina's $8B Grail Deal

A Federal Trade Commission in-house judge has rejected the agency's challenge to Illumina's $8 billion reacquisition of cancer testing outfit Grail, Illumina said Thursday, ending an important chapter in the fight...

Already a subscriber? Click here to view full article